http://onlinelibrary.wiley.com/doi/10.1111/jpi.12300/abstract
DOI: 10.1111/jpi.12300
This article is protected by copyright. All rights reserved.
Issue
Additional Information(Show All)
- This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article as doi: 10.1111/jpi.12300
- Abstract
- Cited By
Keywords:
- Melatonin;
- Subarachnoid hemorrhage;
- Early brain injury;
- Inflammasome;
- Nucleotide binding and oligomerization domain-like receptor family pyrin domain-containing 3
Abstract
Subarachnoid
hemorrhage (SAH) is a devastating condition with high morbidity and
mortality rates due to the lack of effective therapy. Nucleotide binding
and oligomerization domain-like receptor family pyrin domain-containing
3 (NLRP3) inflammasome activation associated with the upregulation of
apoptotic signaling pathway has been implicated in various inflammatory
diseases including hemorrhagic insults. Melatonin is reported to possess
substantial anti-inflammatory properties, which is beneficial for early
brain injury (EBI) after SAH. However, the molecular mechanisms have
not been clearly identified. The current study was designed to
investigate the protective effects of melatonin against EBI induced by
SAH and to elucidate the potential mechanisms. The adult mice were
subjected to SAH. Melatonin or vehicle was injected intraperitoneally 2 h
after SAH. Melatonin was neuroprotective, as shown by increased
survival rate, as well as elevated neurological score, greater survival
of neurons, preserved brain glutathione levels and reduced brain edema,
malondialdehyde concentrations, apoptotic ratio, and blood brain barrier
(BBB) disruption. Melatonin also attenuated the expressions of NLRP3,
apoptosis-associated speck-like protein containing a caspase recruitment
domain (ASC), cleaved caspase-1, interleukin-1β (IL-1β),
and interleukin-6 (IL-6); these changes were also associated with an
increase in the anti-apoptotic factor (Bcl2) and reduction in the
pro-apoptotic factor (Bim). In summary, our results demonstrate that
melatonin treatment attenuates the EBI following SAH by inhibiting NLRP3
inflammasome-associated apoptosis.
This article is protected by copyright. All rights reserved.
No comments:
Post a Comment